Main Programme 2016-10-12T13:00:49+00:00

Main Programme

Peripheral CX37 Vascular & Endovascular Controversies Update - Day 1 PERIPHERAL ARTERIAL CONTROVERSIES - Tuesday, 28th April Basic principles and imaging Chairing: Cliff Shearman, Southampton, United KingdomModerator: Ian Franklin, Imperial College, London, United Kingdom 08:00-08:10Essential management for every patient with intermittent claudication before consideration of interventionSpeaker: Frans Moll, Utrecht, Netherlands 08:10-08:15Discussion 08:15-08:253D lower limb perfusion during critical limb ischaemiaSpeaker: Andrew Holden, Auckland, New Zealand 08:25-08:30Discussion 08:30-08:40Contrast reduction angiography for peripheral arterial diseaseSpeaker: Martin Malina, Malmö, Sweden 08:40-08:45Discussion 08:45-08:55Debate: Debate: IVUS is worth the cost for peripheral arterial diseaseFor the motion: Fabrizio Fanelli, Rome, Italy Against the motion: Patrick Peeters, Bonheiden, Belgium 08:55-09:00Discussion and vote 09:00-09:10There is no advantage using heparin with intra-arterial thrombolysisSpeaker: Anders Wanhainen, Uppsala, Sweden 09:10-09:15Discussion 09:15-09:25Definition of success of superficial femoral artery interventionsSpeaker: Peter Schneider, Honolulu, HI, 09:25-09:30Discussion Iliac reconstruction controversies 09:30-09:40Early clinical outcomes with a new flexible endoluminal stent graft for iliac artery diseaseSpeaker: Andrew Holden, Auckland, New Zealand 09:40-09:45Discussion Superficial femoral artery (SFA) controversies 09:45-09:55Debate: Debate: Endovascular beats open surgery for TASC C & D SFA lesions irrespective of lesion locationFor the motion: Thomas Zeller, Bad Krozingen, Germany Against the motion: Malcolm Simms, Birmingham, United Kingdom 09:55-10:00Discussion and vote COFFEE Preference to use a stent in the superficial femoral artery - This coffee break session is sponsored by Abbott Vascular through the provision of an unrestricted educational grant Chairing: Michael Jaff, Boston, United States 10:00-10:03Coffee & snacks 10:03-10:09My stent rate for the superficial femoral artery rate is increasingSpeaker: Andrew Holden, Auckland, New Zealand 10:09-10:12Discussion 10:12-10:18The European clinical experience of SUPERASpeaker: Iris Baumgartner, Bern, Switzerland 10:18-10:21Discussion 10:21-10:28Chair's case discussion with audience interactionSpeaker: Michael Jaff, Boston, United States The "Leaving nothing behind" controversy Chairing: Roger Greenhalgh, Imperial College, London, United KingdomModerator: Iris Baumgartner, Bern, Switzerland 10:30-10:37Biosorbable stent - 480° BiomedicalSpeaker: Andrew Holden, Auckland, New Zealand 10:37-10:44DEFINITIVE AR atherectomy and drug-coated balloons at one yearSpeaker: Thomas Zeller, Bad Krozingen, Germany 10:44-10:51EverFlex - Seven-year dataSpeaker: Giovanni Torsello, Muenster, Germany 10:51-10:58The FREEDOM trial – a one-handed delivery system for same-day dischargeSpeaker: Yann Goueffic, Nantes, France 10:58-11:05Shockwave Lithoplasty for calcified arterySpeaker: Andrew Holden, Auckland, New Zealand 11:05-11:22Panel discussion Drug-coated balloon update 11:22-11:30Current status of drug eluting balloon use in the superficial femoral arterySpeaker: Fabrizio Fanelli, Rome, Italy 11:30-11:38Update on Lutonix drug eluting balloonSpeaker: Dierk Scheinert, Leipzig, Germany 11:38-11:06ILLUMENATE study - 24-month resultsSpeaker: Stephan Duda, Berlin, Germany 11:46-11:54IN.PACT SFA updateSpeaker: Gunnar Tepe, Rosenheim, Germany 11:54-12:02Cost-effectiveness of drug-coated balloonsSpeaker: Michael Jaff, Boston, MA, 12:02-12:10Methodology differencesSpeaker: Thomas Zeller, Bad Krozingen, Germany 12:10-12:30Panel discussion on drug coated balloons and algorithm of care LUNCH 12:30-13:00Industry Sponsored Satellite - see Industry Sponsored Satellite sections for more information 13:00-13:30Industry Sponsored Satellite - see industry Sponsored Satellites sections for more information Increasing lesion length options and various stent controversies Chairing: Roger Greenhalgh, Imperial College, London, United KingdomModerator: Andrew Holden, Auckland, New Zealand 13:30-13:38Paradigms and importance of lesion length and typeSpeaker: William Gray, New York, United States 13:38-13:41Discussion 13:41-13:49Lower profile robotic catheter use for internal prosthetic bypassesSpeaker: Alan B Lumsden, Houston, United States 13:49-13:52Discussion 13:52-14:00Zilver PTX – final results at five yearsSpeaker: Michael Dake, Stanford, United States 14:00-14:03Discussion 14:03-14:11The value of drug elution on a new bare metal stent - SuperNova to MajesticSpeaker: Richard Powell, Lebanon, United States 14:11-14:14Discussion 14:14-14:22Lesion up to 100mmKonstantinos Katsanos, London, United Kingdom 14:22-14:25Discussion 14:25-14:33The SUPERA stent for superficial femoral artery lesions even with calcificationFiras Mussa, New York, NY, United States 14:33-14:36Discussion 14:36-14:44The value of Smart Flex for femoropopliteal diseaseSpeaker: Peter Goverde, Antwerp, Belgium 14:44-14:47Discussion 14:47-14:55Stent graft and double stent graft for very long lesions in the SFASpeaker: Daniele Savio, Turin, Italy 14:55-14:58Discussion 14:58-15:06Long-term results of laser and drug-eluting balloon for in-stent restenosisSpeaker: Jos van den Berg, Lugano, Switzerland 15:06-15:09Discussion 15:09-15:30Panel discussion on stent usage and longer lesions TEA 15:30-16:00Industry Sponsored Satellite - see industry Sponsored Satellites sections for more information Open surgical controversy Chairing: Paul Blair, Belfast, United KingdomModerator: Cliff Shearman, Southampton, United Kingdom 16:00-16:10Debate: Debate: Heparin bonding benefits superficial femoral artery PTFE bypass resultsFor the motion: Russell Samson, Sarasota, FL, Against the motion: Jonathan Beard, Sheffield, United Kingdom 16:10-16:20Discussion and vote Popliteal debate 16:20-16:30Debate: Debate: Popliteal aneurysm should be treated by endovascular meansFor the motion: Michele Antonello, Italy Against the motion: Martin Bjorck, Sweden 16:30-16:40Discussion and vote Below the knee Chairing: Frans Moll, Utrecht, NetherlandsModerator: Michael Edmonds, London, United Kingdom 16:40-16:48Definition of critical limb ischaemiaSpeaker: Jim Reekers, Amsterdam, Netherlands 16:48-16:56Appraisal of rotational atherectomy in calcified infrapopliteal lesionsSpeaker: Fabrizio Fanelli, Rome, Italy 16:56-17:04The angiosome concept is convincingSpeaker: Maarit Venermo, Helsinki, Finland 17:04-17:12Current status of below-the-knee interventionsSpeaker: Thomas Zeller, Bad Krozingen, Germany 17:12-17:30Influence of steroid on chronic limb ischaemia – similar in severity to the nephropathic footSpeaker: Iris Baumgartner, Bern, Switzerland 17:20-17:28PADI trial one-year results – drug-eluting stents vs. PTASpeaker: Hans van Overhagen, Den Haag, Netherlands 17:28-17:36Lower restenosis of long below-the-knee lesions at 6 months with everolimus-eluting stent vs. paclitaxel-coated balloonSpeaker: Konstantinos Katsanos, London, United Kingdom 17:36-18:00Panel discussion on effectiveness of treatment options Aortic CX37 Vascular & Endovascular Controversies Update - Day 2 ABDOMINAL AORTIC CONTROVERSIES - Wednesday, 29th April Epidemiology, indications and medical management Chairing: Andrew Holden, Auckland, New ZealandModerator: Giovanni Torsello, Münster, Germany 08:00-08:08Life style other than smoking and the risk for abdominal aortic aneurysmSpeaker: Frank Lederle, Minneapolis, MN, 08:08-08:11Discussion 08:11-08:19Factors associated with abdominal aortic aneurysm expansion and ruptureSpeaker: Janet Powell, Imperial College, London, United Kingdom 08:19-08:22Discussion 08:22-08:30Threshold for elective interventionSpeaker: Kevin Mani, Uppsala, Sweden 08:30-08:33Discussion 08:33-08:41Endovascular indications for embolising aortic lesionsMichel Makaroun, Pittsburgh, United States 08:41-08:44Discussion Ruptured abdominal aortic aneurysm 08:44-08:52Intraoperative CT in EVAR is also helpful in ruptured casesSpeaker: Dittmar Boeckler, Heidelberg, Germany 08:52-08:55Discussion 08:55-09:03IMPROVE trial – net benefit results at 12 monthsSpeaker: Janet Powell, London, United Kingdom 09:03-09:06Discussion 09:06-09:14Twelve-month outcomes – IPD 3 trialSpeaker: Ron Balm, Amsterdam, Netherlands 09:14-09:17Discussion 09:17-09:25Responsibilities of disciplines after ruptured abdominal aortic aneurysm by day and nightSpeaker: Jan de Waele, Ghent, Belgium 09:25-09:28Discussion 09:28-09:38Debate: Debate: Too many patients with rAAA are denied interventionFor the motion: Matt Thompson, London, United Kingdom Against the motion: Peter Lamont, Bristol, United Kingdom 09:38-09:43Discussion and vote 09:43-10:00Panel discussion COFFEE 10:00-10:30Industry Sponsored Satellite - see industry Sponsored Satellites sections for more information Procedures for infra-renal abdominal aortic neck <15mm – elective and for rupture Chairing: Roger Greenhalgh, Imperial College, London, United KingdomModerator: Frans Moll, Utrecht, Netherlands 10:30-10:38Morphology findings from the IMPROVE trialSpeaker: Robert Hinchliffe, London, United Kingdom 10:38-10:41Discussion 10:41-10:49EVAR alone is first choice for aortic neck <15mmSpeaker: Hence Verhagen, Rotterdam, Netherlands 10:49-10:52Discussion 10:52-11:00Open repair is best more often than notSpeaker: Jürg Schmidli, Bern, Switzerland 11:00-11:03Discussion 11:03-11:11Choice of device for short neck and appraisal of FEVARSpeaker: Timothy Resch, Malmo, Sweden 11:11-11:14Discussion 11:14-11:22The place for parallel graftsSpeaker: Mario Lachat, Zurich, Switzerland 11:22-11:25Discussion 11:25-11:33Treatment of juxta renal aneurysms with parallel grafts and polymer based technologySpeaker: Matt Thompson, London, United Kingdom 11:33-11:36Discussion 11:36-11:44Potential benefit from robotic navigation with 3D imaging for complex anatomy and endovascular proceduresSpeaker: Alan B Lumsden, Houston, TX, 11:44-11:47Discussion 11:47-11:55The value of polymer-filled sealing ring technology for abdominal aortic aneurysmSpeaker: David Minion, Lexington, KY, United States 11:55-11:58Discussion 11:58-12:08Debate: Debate: EVAR is not sensible for any abdominal aortic aneurysm with a neck length less than 10mm.For the motion: Stephen Cheng, Hong Kong, Hong Kong Against the motion: Jan Blankensteijn, Amsterdam, Netherlands 12:08-12:13Discussion and vote 12:13-12:30Panel discussion on short infrarenal aortic neckDiscussant: Rao Vallabhaneni, Liverpool, United Kingdom LUNCH 12:30-13:00Industry Sponsored Satellite - see industry Sponsored Satellites sections for more information Results of INCRAFT at 3 years This lunch break session is sponsored by Cordis through the provision of an unrestricted educational grant Chairing: Eric Ducasse, Bordeaux, France 13:02-13:10The INNOVATION study at 3 years – accuracy of placementSpeaker: Giovanni Pratesi, Florence, Italy 13:10-13:15Discussion 13:15-13:23High expectations of cost-effectivenessSpeaker: Arne Schwindt, Munster, Germany 13:23-13:28Discussion Mini-symposium: Radiation exposure to operator and patient Chairing: Frans Moll, Utrecht, NetherlandsModerator: Janet Powell, Imperial College, London, United Kingdom 13:30-13:38Radiation levels for mobile, fixed and clarity fixed C-arm fluoroscopySpeaker: Joost van Herwaarden, Utrecht, Netherlands 13:38-13:40Discussion 13:40-13:48Reduction of radiation to all involved in endovascular proceduresSpeaker: Lindsay Machan, Vancouver, Canada 13:48-13:50Discussion 13:50-13:58Reduction of radiation to the operatorSpeaker: Barry Katzen, Miami, FL, 13:58-14:00Discussion 14:00-14:08Doing more with less - dose optimised imaging protocols for complex endovascular proceduresSpeaker: Eric Verhoeven, Nuremberg, Germany 14:08-14:10Discussion 14:10-14:19Panel discussion Technical approaches for elective aneurysm repair 14:19-14:29Launch: Six-month results of a new iliac branch endoprosthesisSpeaker: Darren Schneider, New York, NY, 14:29-14:31Discussion 14:31-14:39Branched iliac device prevents gluteal claudication in aorto-iliac aneurysmsSpeaker: Lars Lönn, Copenhagen, Denmark 14:39-14:41Discussion 14:41-14:49The treatment of aortic graft infection by a technique using femoral vein and fascial strengtheningSpeaker: Maarit Venermo, Helsinki, Finland 14:49-14:51Discussion 14:51-14:59Non-radical management of infected aortic graftsSpeaker: Martin Malina, Malmo, Sweden 14:59-15:01Discussion 15:01-15:09A new repositionable and conformable endograft system for expected improved EVAR deviceSpeaker: Robert Rhee, New York, NY, 15:09-15:11Discussion 15:11-15:19Elective AAA repair in octo- and nonagenariansSpeaker: Kevin Mani, Uppsala, Sweden 15:19-15:21Discussion 15:21-15:30Panel discussion TEA Changing the standard of care with EndoVascular Aneurysm Sealing (EVAS) - This tea break session is sponsored by Endologix through the provision of an unrestricted educational grant Chairing: Andrew Holden, Auckland, New Zealand 15:30-15:38EVAS patient selection and case planningSpeaker: Jan Heyligers, Tilburg, Netherlands 15:38-15:43Discussion 15:43-15:51Radiologic and duplex protocols and appearances for EVASSpeaker: Andrew Winterbottom, Cambridge, United Kingdom 15:51-15:56Discussion 15:56-16:04EVAS for acute AAA - how to do it and early resultsSpeaker: Michel Reijnen, Arnhem, Netherlands 16:04-16:09Discussion 16:09-16:17Building evidence to support EVAS as the next gold standardSpeaker: Matt Thompson, London, United Kingdom 16:17-16:22Discussion 16:22-16:27Panel discussion Follow-up Chairing: Roger Greenhalgh, Imperial College, London, United KingdomModerator: Sebastian Debus, Hamburg, Germany 16:30-16:40Debate: Debate: At least one follow-up visit with imaging, ultrasound or CT each five years is required after EVARFor the motion: Janet Powell, London, United Kingdom Against the motion: Michael Wyatt, Newcastle-upon-Tyne, United Kingdom 16:40-16:45Discussion and vote 16:45-16:53EVAR - surveillance protocol 20 years after EVAR introductionSpeaker: Fabio Verzini, Perugia, Italy 16:53-16:55Discussion 16:55-17:03Performance of new generation endografts in more than 900 patients with different anatomic scenarios: what we have learnedSpeaker: Theodosios Bisdas, Münster, Germany 17:03-17:05Discussion 17:05-17:13The impact of EVAS on secondary interventions compared with EVARSpeaker: Andrew Holden, Auckland, New Zealand 17:13-17:15Discussion 17:15-17:23Endoleak is associated with sac growth but not mortality (OVER trial)Speaker: Frank Lederle, Minneapolis, MN, 17:23-17:25Discussion 17:25-17:35Panel discussion Mini-symposium: Management of type I endoleaks 17:35-17:45Debate: Debate: Liquid embolic products and glues are indicated for type I endoleaksFor the motion: Robert Morgan, London, United Kingdom Against the motion: Fabrizio Fanelli, Rome, Italy 17:45-17:50Discussion and vote 17:50-17:58Extension fenestrated cuffsSpeaker: Stéphan Haulon, Lille, France 17:58-18:00Discussion 18:00-18:08Chimney graftsSpeaker: Giovanni Torsello, Muenster, Germany 18:08-18:10Discussion 18:10-18:18Upward migration and type Ib endoleak years after EVAR - a word of cautionSpeaker: Hence Verhagen, Rotterdam, Netherlands 18:18-18:20Discussion 18:20-18:30Panel discussion Stroke Aortic CX37 Vascular & Endovascular Controversies Update - Day 3 CAROTID CONTROVERSIES - Thursday, 30th April Chairing: Ross Naylor, Leicester, United KingdomModerator: Frans Moll, Utrecht, Netherlands 08:00-08:09Definition of ‘best medical therapy’ for carotid diseaseSpeaker: Martin Brown, London, United Kingdom 08:09-08:11Discussion 08:11-08:20Resistance to platelet inhibitory therapy and stroke risk in patients with carotid diseaseSpeaker: Charles McCollum, Manchester, United Kingdom 08:20-08:22Discussion 08:22-08:32Debate: Debate: Selective carotid screening is justified in modern clinical practiceFor the motion: Peter Schneider, Honolulu, HI, Against the motion: Ankur Thapar, Harlow, United Kingdom 08:32-08:37Discussion and vote 08:37-08:46Carotid artery stenting in the hyperacute period after onset of symptoms: ‘The rule of 5'Speaker: Gioachino Coppi, Bolzano, Italy 08:46-08:48Discussion 08:48-08:57Is there any role for intervention in acute carotid dissection?Speaker: Colin Derdeyn, St. Louis, MO, 08:57-08:59Discussion 08:59-09:08Results of urgent carotid intervention after thrombolysis following strokeSpeaker: Martin Bjorck, Uppsala, Sweden 09:08-09:10Discussion 09:10-09:19An algorithm for predicting late stroke risk in asymptomatic patientsSpeaker: Andrew Nicolaides, London, United Kingdom 09:19-09:21Discussion 09:21-09:30The significance of symptomatic vertebral artery diseaseSpeaker: Hugh Markus, Cambridge, United Kingdom 09:30-09:32Discussion 09:32-09:42Debate: Debate: Robotic navigation improves the results of carotid stentingFor the motion: Celia Riga, London, United Kingdom Against the motion: Trevor Cleveland, Sheffield, United Kingdom 09:42-09:47Discussion and vote 09:47-10:00Panel discussion COFFEE THORACIC AORTIC CONTROVERSIES - Thursday, 30th April Stroke during aortic arch interventions Chairing: Janet Powell, Imperial College, London, United KingdomModerator: Frank Veith, New York, NY, United States 10:30-10:37The frequency of cerebral embolisation after aortic arch catheterisationSpeaker: Richard Gibbs, London, United Kingdom 10:37-10:40Discussion 10:40-10:47The reporting of cerebral embolisation after aortic arch catheterisationSpeaker: Regula von Allmen, St. Gallen, Switzerland 10:47-10:50Discussion 10:50-10:57The value of medication such as statins before aortic arch catheterisationSpeaker: Frank Lederle, Minneapolis, MN, 10:57-11:00Discussion 11:00-11:05Panel discussion 11:05-11:15Debate: Debate: Low profile endovascular aortic devices have more benefits than disadvantagesFor the motion: Eric Verhoeven, Nuremberg, Germany Against the motion: Peter Holt, London, United Kingdom 11:15-11:20Discussion and vote Interventions for ascending and arch of the aorta Chairing: Roger Greenhalgh, Imperial College, London, United KingdomModerator: Matt Thompson, London, United Kingdom 11:20-11:27Micromesh use to reduce cerebral embolisation during carotid stentingSpeaker: Alberto Cremonesi, Cotignola, Italy 11:27-11:30Discussion 11:30-11:37Ascending aortic reconstruction considerationsSpeaker: Rodney White, Torrance, CA, 11:37-11:40Discussion 11:40-11:47TEVAR in the aortic arch – influence of the proximal landing zone on outcomeSpeaker: Dittmar Boeckler, Heidelberg, Germany 11:47-11:50Discussion 11:50-11:57Branched stent grafts for the treatment of complex arch lesionsSpeaker: Piergiorgio Cao, Rome, Italy 11:57-12:00Discussion 12:00-12:07Open surgerySpeaker: Stephen Large, Cambridge, United Kingdom 12:07-12:10Discussion 12:10-12:18Launch: Early clinical experience of a new thoracic branched device for the aortic archSpeaker: Michael Dake, Stanford, CA, 12:18-12:21Discussion 12:21-12:30Panel discussion LUNCH 12:30-13:00Industry Sponsored Satellite - see industry Sponsored Satellites sections for more information Interventions for ascending and arch of the aorta (continued) Chairing: Andrew Holden, Auckland, New ZealandModerator: Colin Bicknell, London, United Kingdom 13:30-13:40Debate: Debate: Hybrid beats total TEVAR wherever it can be usedFor the motion: Franco Grego, Padua, Italy Against the motion: Frans Moll, Utrecht, Netherlands 13:40-13:45Discussion and vote 13:45-13:55Debate: Debate: Endovascular branched graft beats open surgery for the left subclavian arteryFor the motion: Jean M Panneton, Norfolk, VA, United States Against the motion: Marcus Brooks, Westbury on Trim, United Kingdom 13:55-14:00Discussion and vote 14:00-14:08Complex arch and thoracic aortic procedures using robotic systemSpeaker: Thomas Nolte, Bad Bevensen, Germany 14:08-14:10Discussion 14:10-14:20Debate: Debate: The heyday of open aortic surgery is overFor the motion: Frank Veith, New York, NY, Against the motion: Hans-Henning Eckstein, Munich, Germany 14:20-14:25Discussion and vote 14:25-14:35Panel discussion on interventions for ascending and arch of the aorta Controversies in chronic type B dissection of the aorta 14:35-14:44Predictions of clinical success after TEVAR for chronic dissectionSpeaker: Matt Thompson, London, United Kingdom 14:44-14:46Discussion 14:46-14:55Factors that predict success after TEVAR for chronic type B dissectionSpeaker: Hervé Rousseau, Toulouse, France 14:55-14:57Discussion 14:57-15:06Techniques for embolisation of the false lumenSpeaker: Tilo Kölbel, Hamburg, Germany 15:06-15:08Discussion 15:08-15:17Spinal cord protection – related complications in chronic type B dissectionSpeaker: Vincent Riambau, Barcelona, Spain 15:17-15:19Discussion 15:19-15:30Panel discussion on type B dissection of the aorta TEA 15:30-16:00Industry Sponsored Satellite - see industry Sponsored Satellites sections for more information Current best practice in the management of chronic type B dissection Chairing: Matt Thompson, London, United KingdomModerator: Dittmar Boeckler, Heidelberg, Germany 16:00-16:10Debate: Debate: Long-term results following intervention for sub-acute uncomplicated type B dissection warrant interventionFor the motion: Christoph Nienaber, Rostock, Germany Against the motion: Ross Milner, Chicago, IL, United States 16:10-16:15Discussion and vote 16:15-16:23Dissection algorithmSpeaker: Michael Dake, Stanford, CA, 16:23-16:25Discussion 16:25-16:33The impact of timing in the treatment of acute dissectionSpeaker: Nimesh Desai, Philadelphia , PA, 16:33-16:35Discussion Descending thoracic aorta, thoracoabdominal and juxtarenal 16:35-16:43MR elastography for optimal durability of thoracic endograftsSpeaker: Rachel Clough, London, United Kingdom 16:43-16:45Discussion 16:45-16:53Risk score for open repair, EVAR and thoracic interventionsSpeaker: Ian Loftus, London, United Kingdom 16:53-16:55Discussion 16:55-17:05Debate: Debate: The threshold diameter for intervention of the thoracic aorta is unknownFor the motion: Janet Powell, London, United Kingdom Against the motion: Vincent Riambau, Barcelona, Spain 17:05-17:10Discussion and vote 17:10-17:18Two-stage TEVAR yields lower mortality and more protection against spinal cord injurySpeaker: Matthew J Eagleton, Cleveland, OH, 17:18-17:20Discussion 17:20-17:28Renal revascularisation during open TAAA with Hybrid Vascular GraftSpeaker: Roberto Chiesa, Milan, Italy 17:28-17:30Discussion 17:30-17:38Strategies to reduce paraplegia after TAAA repair (endovascular and open)Speaker: Theodosios Bisdas, Münster, Germany 17:38-17:40Discussion 17:40-18:00Panel discussion Venous CX37 Vascular & Endovascular Controversies Update - Day 4 VENOUS CONTROVERSIES - Friday, 1st May Superficial venous controversies Chairing: Ian Franklin, Imperial College, London, United KingdomModerator: Mark Whiteley, Guildford, United Kingdom Truncal ablation Thermal Radiofrequency methods and their differences 08:00-08:07Five-year data using a 7cm catheter systemSpeaker: Olivier Pichot, Grenoble, France 08:07-08:09Discussion 08:09-08:16Benefits of bipolar radiofrequency technologySpeaker: Isaac Nyamekye, Worcester, United Kingdom 08:16-08:18Discussion 08:18-08:25The unipolar approach for radiofrequencySpeaker: Attila Szabo, Budapest, Hungary 08:25-08:27Discussion Endovenous Laser Therapy 08:27-08:34Laser fibre types - design and outcomeSpeaker: Ian Chetter, Hull, United Kingdom 08:34-08:36Discussion 08:36-08:46Panel discussion on thermal truncal ablation Non-thermal 08:46-08:53The mechanochemical method of ablation comes of ageSpeaker: Alun Davies, Imperial College, London, United Kingdom 08:53-08:55Discussion 08:55-09:02Endovenous glue ablation - VaricloseSpeaker: Kursat Bozkurt, Istanbul, Turkey 09:02-09:04Discussion 09:04-09:11The use of cyanoacrylate adhesive for the treatment of refluxing great saphenous vein - VenaSealSpeaker: Guido Lengfellner, Regensburg, Germany 09:11-09:13Discussion 09:13-09:20A comparison of thermal and non-thermal ablationTristan Lane, London, United Kingdom 09:20-09:22Discussion 09:22-09:29Optimal results of foam sclerotherapySpeaker: Attilio Cavezzi, San Benedetto del Tronto, Italy 09:29-09:31Discussion 09:31-09:38Foam phlebectomy techniques and outcomesSpeaker: Michael Cumming, St. Louis Park, MN, United States 09:38-09:40Discussion 09:40-09:50Panel discussion on non-thermal truncal ablation Perforating vein intervention 09:50-09:57Identification of those that need correctingSpeaker: Barrie Price, Guildford, United Kingdom 09:57-10:00Discussion COFFEE Venous thrombosis – incidence, consequence and towards a Patient Pathway - This coffee break session is sponsored by Boston Scientific through the provision of an unrestricted educational grant Chairing: Fabrizio Fanelli, Rome, Italy 10:03-10:09From venous thrombosis to post-thrombotic syndromeSpeaker: Marzia Lugli, Modena, Italy 10:09-10:12Discussion 10:12-10:18Building an interventional pathwaySpeaker: Gerard O'Sullivan, Galway, Ireland 10:18-10:21Discussion 10:21-10:28Chair's case discussion with audience interaction Sclerotherapy and laser therapy of thread veins Chairing: Ian Franklin, Imperial College, London, United KingdomModerator: Stephen Black, London, United Kingdom 10:30-10:40Debate: Duplex scanning is mandatory before treatment of asymptomatic cosmetic thread veinsFor the motion: Mark Whiteley, Guildford, United Kingdom Against the motion: Alun Davies, London, United Kingdom 10:40-10:45Discussion and vote 10:45-10:52Thread veins need compressionSpeaker: Philip Coleridge-Smith, London, United Kingdom 10:52-10:54Discussion Superficial and deep venous imaging Chairing: Alun Davies, Imperial College, London, United KingdomModerator: Ian Franklin, Imperial College, London, United Kingdom 10:54-11:01The algorithm of choice of imaging modality, duplex, venography and IVUS and the place of CT and MR venographySpeaker: Stephen Black, East Horsley, United Kingdom 11:01-11:03Discussion 11:03-11:10Improved clinical outcomes consequent upon excellent pelvic imagingSpeaker: Mark Whiteley, Guildford, United Kingdom 11:10-11:12Discussion 11:12-11:19CT and MR venography and the limitations of venography in the lying positionSpeaker: Narayan Karunanithy, London, United Kingdom 11:19-11:21Discussion 11:21-11:28The measurement of a deep venous stenosisSpeaker: Carsten Arnoldussen, Netherlands 11:28-11:30Discussion 11:30-11:37The range of use of state-of-the-art duplex scanning in experienced handsSpeaker: Judith Holdstock, Guildford, United Kingdom 11:37-11:39Discussion 11:39-12:05Panel discussion on venous imaging Venous interventions and pathways 12:05-12:12The use of coils and foam into pelvic veinsSpeaker: Anthony Lopez, London, United Kingdom 12:12-12:14Discussion 12:14-12:21Optimal care pathway for a leg ulcer patientSpeaker: Manj Gohel, Cambridge, United Kingdom 12:21-12:23Discussion 12:23-12:30Panel discussion on venous interventions and pathways LUNCH - Announcement of the winners of the CX Abstract prize Deep venous controversies Chairing: Stephen Black, United KingdomModerator: Alun Davies, United Kingdom Deep venous stents Chairing: Stephen Black, London, United KingdomModerator: Alun Davies, United Kingdom 13:30-13:37The value of IVUS in planning and deployment of deep venous stentsSpeaker: Marzia Lugli, Modena, Italy 13:37-13:39Discussion 13:39-13:46The Zilver Vena stentSpeaker: Gerard O'Sullivan, Galway, Ireland 13:46-13:48Discussion 13:48-13:55The VENITI stentSpeaker: Olivier Hartung, Marseille, France 13:55-13:57Discussion 13:57-14:04The sinus-Venous stentSpeaker: Rick de Graaf, Maastricht, Netherlands 14:04-14:06Discussion 14:06-14:16Panel discussion on deep venous stents Catheter-directed thrombolysis and thrombectomy 14:16-14:23Methods to estimate the age and nature of a deep venous occlusionSpeaker: Prakash Saha, London, United Kingdom 14:23-14:25Discussion 14:25-14:32Evidence base is needed to change management of acute deep vein thrombosisSpeaker: Ander Cohen, London, United Kingdom 14:32-14:34Discussion 14:34-14:41Acoustic energy thrombolytic technology for remote clot removal, including pulmonary embolism - EKOSSpeaker: Julian Hague, London, United Kingdom 14:41-14:43Discussion 14:43-14:50Reconstruction of the inferior vena cava and Angiovac for inferior vena cava occlusionSpeaker: Iris Baumgartner, Bern, Switzerland 14:50-14:52Discussion 14:52-14:59Detachment of occlusive thrombus in deep vein, aspiration, fragmentation and removal from veins or arteries - Rotarex and AspirexSpeaker: Michael Lichtenberg, Arnsberg, Germany 14:59-15:01Discussion 15:01-15:08Breaking of thrombus and removal from peripheral veins and arteries - AngioJetSpeaker: Gerard O'Sullivan, Galway, Ireland 15:08-15:10Discussion 15:19-15:30Panel discussion on catheter-directed thrombolysis and thrombectomy